GD2-targeting CAR T-cell therapy for patients with GD2+ medulloblastoma. Ciccone R, Quintarelli C, Camera A, Pezzella M, et al. Clin Cancer Res 2024 Mar 29. doi: 10.1158/1078-0432.CCR-23-1880.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ciccone R, Quintarelli C, Camera A, Pezzella M, et al. GD2-targeting CAR T-cell therapy for patients with GD2+ medulloblastoma. Clin Cancer Res 2024 Mar 29. doi: 10.1158/1078-0432.CCR-23-1880.
PMID: 38551501